Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366859 · ClinicalTrials.gov registry record · Phase 2
Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior
A Phase 2 study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT01366859 is a Phase 2 study that has completed, run by Nova Southeastern University. The registered enrollment target is 81 participants.
The verdict
NCT01366859, a Phase 2 study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
This study will evaluate the effects of a cysteine-rich whey protein isolate supplement (Immunocal®) on autistic behavior in pre-school children with autism.
Interventions
- DIETARY_SUPPLEMENT Whey Protein
- DIETARY_SUPPLEMENT Rice Protein (Placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2011-05 |
| Est. Completion | 2016-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366859
The ClinicalTrials.gov registry entry for NCT01366859 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Whey Protein is the first listed.
NCT01366859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366859 about?
NCT01366859 is a clinical study titled "Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior". This study will evaluate the effects of a cysteine-rich whey protein isolate supplement (Immunocal®) on autistic behavior in pre-school children with autism.
What is the current status of trial NCT01366859?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2011-05. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01366859?
The interventions under investigation include: Whey Protein (DIETARY_SUPPLEMENT), Rice Protein (Placebo) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01366859?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.